BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 3485654)

  • 1. The role of receptors for complement in the induction of polyclonal B-cell proliferation and differentiation.
    Tedder TF; Weis JJ; Clement LT; Fearon DT; Cooper MD
    J Clin Immunol; 1986 Jan; 6(1):65-73. PubMed ID: 3485654
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proliferation of resting B cells is modulated by CR2 and CR1.
    Fingeroth JD; Heath ME; Ambrosino DM
    Immunol Lett; 1989 Jun; 21(4):291-301. PubMed ID: 2527816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of a 145,000 Mr membrane protein as the C3d receptor (CR2) of human B lymphocytes.
    Weis JJ; Tedder TF; Fearon DT
    Proc Natl Acad Sci U S A; 1984 Feb; 81(3):881-5. PubMed ID: 6230668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monoclonal antibodies to the human C3b/C4b receptor (CR1) enhance specific B cell differentiation.
    Weiss L; Delfraissy JF; Vazquez A; Wallon C; Galanaud P; Kazatchkine MD
    J Immunol; 1987 May; 138(9):2988-93. PubMed ID: 2952731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell cycle control of a Burkitt lymphoma cell line: responsiveness to growth signals engaging the C3D/EBV receptor.
    Pernegger G; Schulz TF; Hosp M; Myones BL; Petzer AL; Eigentler A; Böck G; Wick G; Dierich MP
    Immunology; 1988 Oct; 65(2):237-41. PubMed ID: 2461345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epstein-Barr virus/complement fragment C3d receptor (CR2) reacts with p53, a cellular antioncogene-encoded membrane phosphoprotein: detection by polyclonal anti-idiotypic anti-CR2 antibodies.
    Barel M; Fiandino A; Lyamani F; Frade R
    Proc Natl Acad Sci U S A; 1989 Dec; 86(24):10054-8. PubMed ID: 2557614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. gp140, a C3b-binding membrane component of lymphocytes, is the B cell C3dg/C3d receptor (CR2) and is distinct from the neutrophil C3dg receptor (CR4).
    Frade R; Myones BL; Barel M; Krikorian L; Charriaut C; Ross GD
    Eur J Immunol; 1985 Dec; 15(12):1192-7. PubMed ID: 3878789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of murine complement receptor type 2 and its immunological cross-reactivity with type 1 receptor.
    Kinoshita T; Thyphronitis G; Tsokos GC; Finkelman FD; Hong K; Sakai H; Inoue K
    Int Immunol; 1990; 2(7):651-9. PubMed ID: 1703784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Binding of monoclonal antibody to the Epstein Barr virus (EBV)/CR2 receptor induces activation and differentiation of human B lymphocytes.
    Nemerow GR; McNaughton ME; Cooper NR
    J Immunol; 1985 Nov; 135(5):3068-73. PubMed ID: 2995485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ligand-loaded but not free complement receptors for C3b/C4b and C3d co-cap with cross-linked B cell surface IgM and IgD.
    Tsokos GC; Thyphronitis G; Jack RM; Finkelman FD
    J Immunol; 1988 Aug; 141(4):1261-6. PubMed ID: 2969399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human follicular dendritic cells express CR1, CR2, and CR3 complement receptor antigens.
    Reynes M; Aubert JP; Cohen JH; Audouin J; Tricottet V; Diebold J; Kazatchkine MD
    J Immunol; 1985 Oct; 135(4):2687-94. PubMed ID: 2411809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The B cell surface molecule B1 is functionally linked with B cell activation and differentiation.
    Tedder TF; Boyd AW; Freedman AS; Nadler LM; Schlossman SF
    J Immunol; 1985 Aug; 135(2):973-9. PubMed ID: 3925015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of a spontaneously shed fragment of B cell complement receptor type two (CR2) containing the C3d-binding site.
    Myones BL; Ross GD
    Complement; 1987; 4(2):87-98. PubMed ID: 3497773
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased expression of the C3b/C4b receptor (CR1) and the C3d receptor (CR2) on B lymphocytes and of CR1 on neutrophils of patients with systemic lupus erythematosus.
    Wilson JG; Ratnoff WD; Schur PH; Fearon DT
    Arthritis Rheum; 1986 Jun; 29(6):739-47. PubMed ID: 2941021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of CR1 and CR2 complement receptors following Epstein-Barr virus infection of Burkitt's lymphoma cell lines.
    Cohen JH; Fischer E; Kazatchkine MD; Lenoir GM; Lefevre-Delvincourt C; Revillard JP
    Scand J Immunol; 1987 Jun; 25(6):587-98. PubMed ID: 3037684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epstein-Barr virus receptor of human B lymphocytes is the C3d receptor CR2.
    Fingeroth JD; Weis JJ; Tedder TF; Strominger JL; Biro PA; Fearon DT
    Proc Natl Acad Sci U S A; 1984 Jul; 81(14):4510-4. PubMed ID: 6087328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of monoclonal antihuman-B-cell antibody BL13 as an anti-C3d-receptor (CR2) antibody.
    Cohen JH; Fischer E; Kazatchkine MD; Brochier J; Revillard JP
    Scand J Immunol; 1986 Mar; 23(3):279-85. PubMed ID: 2419969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monoclonal antibodies to the 140,000 mol wt glycoprotein of B lymphocyte membranes (CR2 receptor) initiates proliferation of B cells in vitro.
    Wilson BS; Platt JL; Kay NE
    Blood; 1985 Oct; 66(4):824-9. PubMed ID: 2931142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of the membrane receptor for the complement fragment C3d by means of a monoclonal antibody.
    Iida K; Nadler L; Nussenzweig V
    J Exp Med; 1983 Oct; 158(4):1021-33. PubMed ID: 6225820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epstein Barr virus binding induces internalization of the C3d receptor: a novel immunotoxin delivery system.
    Tedder TF; Goldmacher VS; Lambert JM; Schlossman SF
    J Immunol; 1986 Aug; 137(4):1387-91. PubMed ID: 3016095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.